TrialHub Wins The Innovation Award at Clinical Trials Arena Excellence Awards 2024
We are excited to announce that TrialHub has been honored with the Innovation Award at the 2024 Clinical Trials Arena Excellence Awards for our groundbreaking AI-driven data intelligence platform, TrialHub IQ. This prestigious accolade recognizes the transformative impact of TrialHub IQ on clinical trial planning and patient engagement.
TrialHub IQ leverages advanced AI technologies, including natural language processing (NLP) and machine learning (ML), to revolutionize data analysis in clinical trials. By integrating over 80,000 pre-validated data sources with our clients’ proprietary datasets, TrialHub IQ provides real-time, actionable insights on countries, sites, and patients that streamline the planning of clinical trials and enhance decision-making.
Our CEO, Maya Zlatanova, highlighted the significance of this achievement, saying:
Maya Zlatanova also emphasized that TrialHub IQ’s ability to provide reliable, short answers from validated sources, along with full visibility of data origins, is a game-changer for the industry. The platform’s unique conversational query interface allows users to interact with the system naturally, obtaining critical insights efficiently.
One of the standout features of TrialHub IQ is its capacity to convert qualitative patient feedback into quantitative data. This capability has already significantly improved patient-centricity in clinical trials, enabling better understanding of patient needs and experiences. By analyzing patient interviews, Standard of Care data, and patient-reported outcomes, TrialHub IQ ensures that clinical trials are designed with the patient journey in mind.
The award-winning platform has already proven its value in real-world applications. In a recent case, TrialHub IQ helped a top pharmaceutical company avoid a substantial amendment, saving them $16 million and accelerating patient recruitment by 3 to 6 months. These results underscore the platform’s potential to prevent costly trial amendments and address recruitment challenges effectively.
We are committed to further enhancing TrialHub IQ’s capabilities. Upcoming developments include expanding our global access to country-specific Standard of Care data and integrating clients’ proprietary research to create custom databases. These advancements will continue to empower clinical trial teams with unparalleled insights, fostering more efficient and effective trial planning.
We extend our gratitude to the Clinical Trials Arena Excellence Awards for this recognition and to our dedicated team and partners who have made this achievement possible. We remain dedicated to driving innovation in clinical trial data intelligence and improving patient outcomes worldwide.
For more information about TrialHub and our award-winning platform, please visit our website.
